ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Initial results of inhibitor combination against breast and gynaecologic cancers

Patient empowerment and quality of life

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Fertility-preserving procedures in BRCA mutation-positive breast cancer

Nivolumab and ipilimumab for metastatic kidney cancer

Biological insight in new drug combinations

Checkmate 238: Adjuvant checkpoint therapy after melanoma resection

The role of tumour marker testing in early diagnosis

The METRIC trial of trametinib, five years on

Treatment choices in thyroid cancer

Clinical advances in treating colorectal cancer